MANCHESTER, England--(BUSINESS WIRE)--Manchester United (NYSE: MANU; the “Company” and the “Group”) today announced financial results for the 2025 fiscal first quarter ended 30 September 2024. Management Commentary Omar Berrada, Chief Executive Officer, commented, “The season is now well underway for both our men's and women's team, and we are keen to ensure both are as competitive as possible....
MANCHESTER, England--(BUSINESS WIRE)--Manchester United plc (NYSE: MANU), announces that it will report results for the first quarter fiscal 2025 period ended 30 September 2024 via press release on 26 November 2024 at 7:00 AM EST. About Manchester United Manchester United is one of the most popular and successful sports teams in the world, playing one of the most popular spectator sports on Ear...
MANCHESTER, England--(BUSINESS WIRE)--Manchester United plc (NYSE: MANU), is delighted to announce the appointment of Rúben Amorim as Head Coach of the men's first team, subject to work visa requirements. He will join until June 2027 with a club option of an additional year once he has fulfilled his obligations to his current club. He will join Manchester United on Monday 11 November. Rúben is ...
Shares in Manchester United PLC (NYSE:MANU) climbed in New York trading after the club confirmed the dismissal of manager Erik ten Hag. The decision followed United's 2-1 defeat by West Ham, leaving the team with just three wins in nine Premier League games and positioned 14th in the standings.
MANCHESTER, England--(BUSINESS WIRE)--Tiger® Beer becomes the Official Beer Partner of Manchester United, bringing together the iconic Asian Brewer and one of the most popular and successful sports teams in the world, to enhance experiences and deepen engagement with United fans globally. The partnership launches at an exciting moment in Tiger® Beer's bold brand evolution, heralding a new era f...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.